MARKET

RGEN

RGEN

Repligen
NASDAQ
165.46
+4.95
+3.08%
Opening 14:25 01/21 EST
OPEN
161.64
PREV CLOSE
160.51
HIGH
167.00
LOW
157.58
VOLUME
421.81K
TURNOVER
--
52 WEEK HIGH
211.13
52 WEEK LOW
113.50
MARKET CAP
9.27B
P/E (TTM)
-444.1879
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RGEN last week (0113-0117)?
Weekly Report · 1d ago
RBC Capital Keeps Their Buy Rating on Repligen (RGEN)
TipRanks · 01/14 01:49
Weekly Report: what happened at RGEN last week (0106-0110)?
Weekly Report · 01/13 09:10
Repligen Launches CTech SoloVPE PLUS, The Most Advanced UV-based Variable Pathlength System
NASDAQ · 01/06 13:30
Repligen launches the CTech SoloVPE PLUS System
TipRanks · 01/06 12:36
Weekly Report: what happened at RGEN last week (1230-0103)?
Weekly Report · 01/06 09:10
Repligen (RGEN) Shares Cross Above 200 DMA
NASDAQ · 01/03 21:34
Weekly Report: what happened at RGEN last week (1223-1227)?
Weekly Report · 12/30/2024 09:10
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. The Company’s chromatography franchise includes a number of products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. The Company’s TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.